The effects of medicines availability and stock-outs on household's utilization of healthcare services in Dodoma region, Tanzania.


Journal

Health policy and planning
ISSN: 1460-2237
Titre abrégé: Health Policy Plan
Pays: England
ID NLM: 8610614

Informations de publication

Date de publication:
01 Apr 2020
Historique:
accepted: 10 12 2019
pubmed: 17 1 2020
medline: 15 12 2020
entrez: 17 1 2020
Statut: ppublish

Résumé

Low- and middle-income countries have been undertaking health finance reforms to address shortages of medicines. However, data are lacking on how medicine availability and stock-outs influence access to health services in Tanzania. The current study assesses the effects of medicine availability and stock-outs on healthcare utilization in Dodoma region, Tanzania. We conducted a cross-sectional study that combined information from households and healthcare facility surveys. A total of 4 hospitals and 89 public primary health facilities were surveyed. The facility surveys included observation, record review over a 3-month period prior to survey date, and interviews with key staff. In addition, 1237 households within the health facility catchment areas were interviewed. Data from the facility survey were linked with data from the household survey. Descriptive analysis and multivariate logistic regressions models were used to assess the effects of medicine availability and stock-outs on utilization patterns and to identify additional household-level factors associated with health service utilization. Eighteen medicines were selected as 'tracers' to assess availability more generally, and these were continuously available in ∼70% of the time in facilities across all districts over 3 months of review. The main analysis showed that household's healthcare utilization was positively and significantly associated with continuous availability of all essential medicines for the surveyed facilities [odds ratio (OR) 3.49, 95% confidence interval (CI) 1.02-12.04; P = 0.047]. Healthcare utilization was positively associated with household membership in the community health insurance funds (OR 1.97, 95% CI 1.23-3.17; P = 0.005) and exposure to healthcare education (OR 2.75, 95% CI 1.84-4.08; P = 0.000). These results highlight the importance of medicine availability in promoting access to health services in low-income settings. Effective planning and medicine supply management from national to health facility level is an important component of quality health services.

Identifiants

pubmed: 31942625
pii: 5702177
doi: 10.1093/heapol/czz173
pmc: PMC7152726
doi:

Substances chimiques

Drugs, Essential 0

Types de publication

Journal Article

Langues

eng

Pagination

323-333

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.

Références

J Public Health (Oxf). 2005 Mar;27(1):49-54
pubmed: 15590705
PLoS One. 2015 Nov 10;10(11):e0142194
pubmed: 26555896
PLoS Med. 2012;9(6):e1001244
pubmed: 22723748
BMJ Open. 2018 Aug 8;8(8):e019613
pubmed: 30093509
BMC Public Health. 2015 Sep 23;15:951
pubmed: 26399915
Int J Tuberc Lung Dis. 2015 Jun;19(6):640-6
pubmed: 25946352
Health Res Policy Syst. 2013 Sep 24;11:36
pubmed: 24228762
Int J Drug Policy. 2016 Apr;30:66-73
pubmed: 26821555
BMJ Open. 2018 Oct 18;8(10):e023646
pubmed: 30341137
Environ Int. 2017 Jan;98:137-142
pubmed: 27817868
J Fam Pract. 2005 Apr;54(4):344-52
pubmed: 15833226
Health Res Policy Syst. 2019 Jan 30;17(1):11
pubmed: 30700308
PLoS One. 2017 Feb 27;12(2):e0172728
pubmed: 28241032
Health Qual Life Outcomes. 2016 Jun 07;14:85
pubmed: 27267367
BMC Health Serv Res. 2012 Feb 14;12:37
pubmed: 22333560
BMC Health Serv Res. 2015 Aug 15;15:331
pubmed: 26275412
BMC Pregnancy Childbirth. 2014 Mar 19;14:108
pubmed: 24646098
BMC Pharmacol Toxicol. 2015 Dec 23;16:43
pubmed: 26699711
Malawi Med J. 2014 Sep;26(3):83-9
pubmed: 27529016
Environ Health Prev Med. 2013 Jan;18(1):1-9
pubmed: 22949173
BMC Health Serv Res. 2014 May 22;14:234
pubmed: 24884788
J Assoc Nurses AIDS Care. 2016 Sep-Oct;27(5):574-84
pubmed: 27080926
Lancet. 2009 Jan 17;373(9659):240-9
pubmed: 19042012
PLoS One. 2014 Dec 11;9(12):e114762
pubmed: 25500832
Int Health. 2018 Jan 1;10(1):1-3
pubmed: 29325056
Afr Health Sci. 2014 Jun;14(2):322-33
pubmed: 25320580
Am J Public Health. 2016 Oct;106(10):1780-1
pubmed: 27626350
J Pharm Policy Pract. 2019 Feb 25;12:4
pubmed: 30891247
Int J Equity Health. 2014 Mar 19;13:25
pubmed: 24645876
Afr Health Sci. 2014 Dec;14(4):1046-55
pubmed: 25834516
PLoS One. 2019 Feb 12;14(2):e0212125
pubmed: 30753219
Health Policy Plan. 2011 Jul;26 Suppl 1:i20-9
pubmed: 21729914
BMC Health Serv Res. 2013 Oct 27;13:444
pubmed: 24161029
Int J Qual Health Care. 2013 Dec;25(6):682-8
pubmed: 24068242
BMC Health Serv Res. 2016 Aug 30;16:453
pubmed: 27577997
Bull World Health Organ. 2012 Sep 1;90(9):685-92
pubmed: 22984313
PLoS One. 2016 Nov 8;11(11):e0164332
pubmed: 27824876
PLoS One. 2016 Oct 18;11(10):e0164366
pubmed: 27755558
Trop Med Int Health. 2009 Jan;14(1):54-61
pubmed: 19021892
Soc Sci Med. 2005 Oct;61(7):1396-407
pubmed: 16005775
BMC Pediatr. 2016 Mar 15;16:40
pubmed: 26979737
Health Econ Rev. 2015 Dec;5(1):62
pubmed: 26329425
Oman Med J. 2007 Oct;22(3):51-6
pubmed: 22400094
Health Policy. 2011 Mar;99(3):203-9
pubmed: 20965602
J Pharm Policy Pract. 2015 Sep 25;8:23
pubmed: 26413304
Rev Saude Publica. 2016 Dec;50(suppl 2):15s
pubmed: 27982383
Health Policy Plan. 2006 Nov;21(6):459-68
pubmed: 17030551
J Pharm Policy Pract. 2015 Feb 16;8(1):8
pubmed: 25825675
PLoS One. 2018 Jul 11;13(7):e0200265
pubmed: 29995899
Health Policy. 2014 Sep;117(3):374-81
pubmed: 24795290
Int J Equity Health. 2014 Dec 20;13:123
pubmed: 25532714

Auteurs

August Kuwawenaruwa (A)

Ifakara Health Institute, Plot 463, Kiko Avenue Mikocheni, PO Box 78 373, Dar es Salaam, Tanzania.
Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland.
University of Basel, Basel, Switzerland.

Kaspar Wyss (K)

Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland.
University of Basel, Basel, Switzerland.
Swiss Centre for International Health (SCIH), Basel, Switzerland.

Karin Wiedenmayer (K)

Swiss Centre for International Health (SCIH), Basel, Switzerland.
Health promotion and System Strengthening (HPSS), Dodoma, Tanzania.

Emmy Metta (E)

Ifakara Health Institute, Plot 463, Kiko Avenue Mikocheni, PO Box 78 373, Dar es Salaam, Tanzania.
School of Public Health and Social Sciences (SPHSS), Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.

Fabrizio Tediosi (F)

Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland.
University of Basel, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH